- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Internal anal sphincter.
Displaying page 1 of 1.
EudraCT Number: 2007-004114-13 | Sponsor Protocol Number: 956 | Start Date*: 2008-01-07 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: TOPIC LEVETIRACETAM IN ANAL FISSURE. A PILOT STUDY ABOUT EFFECTIVENESS AND TOLERABLENESS | |||||||||||||
Medical condition: Anal fissure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002335-27 | Sponsor Protocol Number: IGG-VIJA-001 | Start Date*: 2005-09-01 | |||||||||||
Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: Botulin Toxin injection for the treatment of Internal Anal Sphincter Achalasia | |||||||||||||
Medical condition: Treatment of internal anal sphincter achalasia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000853-30 | Sponsor Protocol Number: DRGT119C01 | Start Date*: 2019-05-31 | |||||||||||
Sponsor Name:Druggability Technologies Holdings Ltd | |||||||||||||
Full Title: A Randomized, Double-Blind, Adaptive Trial with an Open-Label Treatment Extension to Determine the Efficacy and Safety of Topical DRGT-119 0.1% and 0.2% Gels in Patients with Chronic Anal Fissure | |||||||||||||
Medical condition: chronic anal fissure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001216-11 | Sponsor Protocol Number: FISAN-BOT-2017-01 | Start Date*: 2017-04-25 |
Sponsor Name:Dra. A. Teresa Calderón Duque | ||
Full Title: Usefulness of botulinum toxin type A in the treatment of chronic anal fissure | ||
Medical condition: Chronic anal fissure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002819-60 | Sponsor Protocol Number: FAC-BOTOX | Start Date*: 2021-08-19 |
Sponsor Name:Hospital Universitario de Burgos | ||
Full Title: Treatment of chronic anal fissure with ultrasound-guided intersphincteric infiltration of botulinum toxin A. | ||
Medical condition: Chronic anal fissure | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002882-19 | Sponsor Protocol Number: MCHT001 | Start Date*: 2004-12-10 |
Sponsor Name:Mid Cheshire Hospitals NHS Trust | ||
Full Title: A controlled trial into the benefit of topical perianal glyceryl trinitrate (GTN) as a sphincter relaxant, pre-insertion of ultrasound probe for trans rectal ultrasound (TRUS) guided biopsy of the ... | ||
Medical condition: Prostate Cancer Diagnosis – Pain relief during biopsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003351-65 | Sponsor Protocol Number: RDD110 | Start Date*: 2016-03-16 |
Sponsor Name:RDD Pharma Ltd. | ||
Full Title: The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients with Anal Fissure | ||
Medical condition: Anal Fissure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BG (Completed) PL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003627-54 | Sponsor Protocol Number: 150601 | Start Date*: 2016-05-11 | |||||||||||
Sponsor Name:Tecnimede, Sociedade Técnico-Medicinal, S.A. | |||||||||||||
Full Title: Randomized, multicenter, placebo-controlled, double blind study to assess the efficacy and tolerability of 2% diltiazem hydrochloride in the treatment of chronic anal fissure and a 24 week follow-u... | |||||||||||||
Medical condition: Cronic Anal fissure (CAF) The underlying pathogenesis of chronic anal fissure involves initial local trauma (generally caused by hard stools), resulting in a wound, internal anal sphincter spasm an... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005675-15 | Sponsor Protocol Number: DIL-UBI-DEX-CLOII/2003/003/PT | Start Date*: 2008-10-08 | |||||||||||
Sponsor Name:Tecnimede, Sociedade Técnico-Medicinal S.A. | |||||||||||||
Full Title: Randomized, multicenter, placebo-controlled, single blind study to assess the efficacy and tolerability of a combination of a cream containing ubidecarenone, dexpanthenol and chlorohexidine and a p... | |||||||||||||
Medical condition: Cronic Anal fissure (CAF) The underlying pathogenesis of chronic anal fissure involves initial local trauma (generally caused by hard stools), resulting in a wound, internal anal sphincter spasm an... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) CZ (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003206-25 | Sponsor Protocol Number: NRL001-01/2011(SEFI) | Start Date*: 2012-01-25 | |||||||||||
Sponsor Name:Norgine Ltd | |||||||||||||
Full Title: A multi-centre, phase II, double-blind, randomised, placebo-controlled, parallel group, dose-ranging study in patients with faecal incontinence; to evaluate the efficacy, safety and tolerability of... | |||||||||||||
Medical condition: Faecal incontinence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) CZ (Completed) DE (Completed) ES (Completed) GB (Completed) IT (Completed) HU (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2010-021659-17 | Sponsor Protocol Number: CMMAd/InFe/2011 | Start Date*: 2013-08-14 | |||||||||||
Sponsor Name:Fundación Pública Andaluza Progreso y Salud | |||||||||||||
Full Title: Phase I / II, multicenter, double blind, randomized, comparison of two groups and two doses, to evaluate the safety and efficacy of autologous ASCs in the treatment of fecal incontinence. | |||||||||||||
Medical condition: Patients with incontinence faecal | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002331-34 | Sponsor Protocol Number: ALOFEC-2019 | Start Date*: 2022-11-08 | |||||||||||
Sponsor Name:FIMABIS | |||||||||||||
Full Title: A multicenter, randomized, double-blind Phase IIb study to evaluate the safety and efficacy of the intralesional administration of two doses of expanded allogeneic adipose tissue adult stem mesench... | |||||||||||||
Medical condition: Fecal incontinence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
